Effects of low-intensity pulsed electromagnetic fields on bone microarchitecture, mechanical strength and bone turnover in type 2 diabetic db/db mice.

Author: Li J1,2, Zeng Z3, Zhao Y4, Jing D5, Tang C2, Ding Y6, Feng X7
Affiliation:
1State Key Laboratory of Military Stomatology, Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China.
2Department of Stomatology, the 306th Hospital of PLA, Beijing, 100037, P.R. China.
3Department of Stomatology, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning, 110015, P.R. China.
4Beijing Engineering Research Center of Orthopedic Implants, the First Affiliated Hospital of PLA General Hospital, Beijing, 100048, P.R. China.
5Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China.
6State Key Laboratory of Military Stomatology, Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China. dingyin@fmmu.edu.cn.
7State Key Laboratory of Military Stomatology, Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China. prof.fengxue@outlook.com.
Conference/Journal: Sci Rep.
Date published: 2017 Sep 7
Other: Volume ID: 7 , Issue ID: 1 , Pages: 10834 , Special Notes: doi: 10.1038/s41598-017-11090-7. , Word Count: 210


Type 2 diabetic patients have impaired bone quality, leading to increased fracture risk. Substantial evidence demonstrates that pulsed electromagnetic fields (PEMF) could resist osteopenia/osteoporosis induced by estrogen deficiency and disuse. However, the effects of PEMF on osteopenia/osteoporosis associated with diabetes, especially for more prevalent type 2 diabetes, remain poorly understood. We herein investigated the skeletal effects and mechanisms of PEMF (15 Hz, 20 Gs) on leptin receptor-deficient db/db mice with typical type 2 diabetic symptoms. Our µCT results showed that 12-week PEMF exposure significantly improved both cancellous and cortical bone microarchitecture in db/db mice. Three-point bending and biomechanical indentation testing demonstrated that PEMF improved whole-bone structural properties and tissue-level material properties in db/db mice. PEMF significantly promoted bone formation in db/db mice evidenced by increased serum osteocalcin and bone mineral apposition rate, whereas PEMF exerted no observable alteration in bone resorption. Real-time PCR showed that PEMF upregulated tibial gene expression of osteoblastogenesis-related of canonical Wnt/β-catenin signaling but not osteoclastogenesis-related RANKL-RANK signaling in db/db mice. Our findings demonstrate that PEMF improved bone quantity and quality with obvious anabolic activities in db/db mice, and imply that PEMF might become a clinically applicable treatment modality for improving bone quality in type 2 diabetic patients.

PMID: 28883516 DOI: 10.1038/s41598-017-11090-7

BACK